Literature DB >> 330823

The effect of a drug-resistance factor on recombination and repair of DNA in Escherichia coli K12.

P Oliver, K A Stacey.   

Abstract

The presence in recipient strains of Escherichia coli K12 of the plasmid R46 greatly reduced the yield of recombinants from crosses with several Hfr strains and virtually abolished the formation of recombinants by PI transduction without, however, significantly affecting the transfer of the F prime from a strain carrying Fgal. The R46 plasmid had paradoxical effects on mutability: it appeared to enhance the yield of mutants following irradiation with ultraviolet ligh but it reduced the number of mutants detectable in unirradiated cultures. The effects of this plasmid on ultraviolet survival of the wild type and several mutants defective for recombination and repair have been measured and the results, in the main, confirm similar observation by Tweats et al. (1976). Not only is the survival of the strain habouring R46 greater than that of the parent strain in all the cases studied, but the survival of ultraviolet irradiated bacteriophage lambda is also greater.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330823     DOI: 10.1099/00221287-101-1-93

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  4 in total

1.  LexA-independent expression of a mutant mucAB operon.

Authors:  K P McNally; N E Freitag; G C Walker
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

2.  Plasmid control of recombination of E. coli K12.

Authors:  L S Chernin; M I Ovadis
Journal:  Mol Gen Genet       Date:  1980

3.  DNA repair in Proteus mirabilis. VI. Plasmid (R46-) mediated recovery and UV mutagenesis.

Authors:  J Hofemeister; H Köhler; V D Filippov
Journal:  Mol Gen Genet       Date:  1979-10-03

4.  Effect of pKM101 on cell killing and specificity of mutation induction by cis-diaminedichloroplatinum(II) in Escherichia coli K-12.

Authors:  J Brouwer; M R Adhin; P van de Putte
Journal:  J Bacteriol       Date:  1983-12       Impact factor: 3.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.